Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2

• Published in: Pharmacology, biochemistry and behavior Vol. 213; p. 173338
• Main Authors: D'Souza, Manoranjan S., Seeley, Sarah L., Emerson, Nathaniel, Rose-Malkamaki, Madison J., Ho, Sheng-Ping, Tsai, Yi-Chih, Kuo, Henry, Huan, Ching-Yu, Rorabaugh, Boyd R.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-02-2022
• Subjects: Animals; Anti-Anxiety Agents - pharmacology; Antidepressive Agents - pharmacology; Anxiety; Anxiety - drug therapy; Anxiety - metabolism; Brain; Conditioning, Psychological - drug effects; Depression; Depression - drug therapy; Depression - metabolism; Elevated Plus Maze Test; Female; Locomotion - drug effects; Male; Mice; Nicotine - pharmacology; Reward; RGS; RGS Proteins - metabolism; Smoking; Brain; CPP; mins; EPM; KO; Depression; Anxiety; Reward; WT; RGS; TS; Smoking
• ISSN: 0091-3057; 1873-5177
• DOI: 10.1016/j.pbb.2022.173338

Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above described effects of nicotine. Male and female mice lacking either RGS2 (RGS2 KO) or RGS4 (RGS4 KO), and their respective wildtype (WT) littermates were used in this study. The rewarding effects of nicotine (0.5 mg/kg, base; s.c.) were assessed using the conditioned place preference model. Nicotine-induced anxiolytic-like (0.1 mg/kg, base; i.p.) and antidepressant-like (1 mg/kg, base; i.p.) effects were assessed using the elevated plus maze and tail suspension test, respectively. We also assessed effects of nicotine (0, 0.05, 0.1 & 0.5 mg/kg, base; s.c.) on spontaneous locomotor activity. Nicotine-induced rewarding and antidepressant-like effects were observed in both male and female RGS2 WT mice, but not in mice lacking RGS2 compared to respective controls. In contrast, nicotine-induced rewarding and antidepressant-like effects were observed in both male and female mice lacking RGS4 and their WT littermates. Interestingly, deletion of RGS4 facilitated antidepressant-like effect of nicotine in male, but not female mice compared to respective WT littermates. Nicotine-induced anxiolytic-like effect was not influenced by deletion of either RGS2 or RGS4, irrespective of sex. Nicotine (0.5 mg/kg) decreased locomotor activity in both WT and KO mice compared to respective saline, irrespective of genotype and sex. Taken together, these data provide evidence that RGS2, but not RGS4, plays a role in mediating the rewarding and antidepressant-like effects of nicotine. Further research is required to explore the role of RGS2 after chronic exposure to nicotine.
•Nicotine-induced rewarding effects were attenuated in mice lacking RGS2.•Nicotine-induced antidepressant-like effects were blocked in mice lacking RGS2.•Nicotine-induced rewarding effects were not affected in mice lacking RGS4.•Nicotine-induced antidepressant-like effects were facilitated in male mice lacking RGS4.